Richard Rawson Selected Research

Opioid Analgesics (Opioids)

11/2023	A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated.
1/2023	Expanding access to treatment for stimulant use disorder in a frontier state: A qualitative study of contingency management and TRUST program implementation in Montana.
4/2021	COVID-19: A new barrier to treatment for opioid use disorder in the emergency department.
1/2020	The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?
1/2020	Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.
1/2019	Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system.
1/2017	Trends in Tramadol: Pharmacology, Metabolism, and Misuse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Rawson Research Topics

Disease

10	Substance-Related Disorders (Drug Abuse) 01/2023 - 05/2004
6	Opioid-Related Disorders (Opiate Addiction) 11/2023 - 01/2019
3	Alcoholism (Alcohol Abuse) 01/2018 - 01/2002
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018 - 10/2010
2	Cocaine-Related Disorders (Cocaine Addiction) 07/2012 - 04/2003
2	Disease Progression 04/2009 - 12/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Opiate Overdose 01/2019
1	AIDS-Related Complex (ARC) 01/2018
1	Belonephobia 01/2018
1	Chronic Pain 01/2017
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2013
1	Wounds and Injuries (Trauma) 04/2013
1	Syndrome (Syndromes) 04/2013
1	Feeding and Eating Disorders (Eating Disorder) 05/2011
1	Bulimia Nervosa 05/2011
1	Weight Loss (Weight Reduction) 05/2011
1	Anxiety Disorders (Anxiety Disorder) 09/2010
1	Stomatognathic Diseases (Dental Disease) 03/2010
1	Psychotic Disorders (Schizoaffective Disorder) 12/2008
1	Major Depressive Disorder (Major Depressive Disorders) 03/2008
1	Heroin Dependence (Heroin Abuse) 05/2004
1	Antisocial Personality Disorder (Antisocial Personality) 04/2003
1	Mental Disorders (Mental Disorder) 04/2003

Drug/Important Bio-Agent (IBA)

9	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2023 - 03/2008
7	Opioid Analgesics (Opioids)IBA 11/2023 - 01/2017
2	Methadone (Dolophine)FDA LinkGeneric 01/2023 - 04/2003
2	Buprenorphine (Subutex)FDA LinkGeneric 01/2020 - 05/2004
2	Naltrexone (ReVia)FDA LinkGeneric 01/2018 - 01/2002
2	Opiate AlkaloidsIBA 01/2018 - 01/2002
2	Cocaine (Cocaine HCl)IBA 04/2006 - 04/2003
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2023
1	Naloxone Drug Combination Buprenorphine FDA Link 04/2021
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Tramadol (K315)FDA LinkGeneric 01/2017
1	Topiramate (Topamax)FDA LinkGeneric 07/2012
1	SmokeIBA 03/2010
1	4-aminospiroperidolIBA 04/2003

Therapy/Procedure

5	Aftercare (After-Treatment) 01/2018 - 03/2008
2	Drug Therapy (Chemotherapy) 01/2018 - 06/2011
1	Therapeutics 01/2023
1	Ambulatory Care (Outpatient Care) 06/2011